Abstract
Background: Since 2008 patients with BH4-sensitive phenylketonuria can be treated with sapropterin dihydrochloride (Kuvan®) in addition to the classic phenylalanine (Phe) restricted diet. The aim of this study was to evaluate the nutritional changes and micronutrient supply in patients with phenylketonuria (PKU) under therapy with tetrahydrobiopterin (BH4).
Subjects and Methods: 19 children with PKU (4–18 years) and potential BH4-sensitivity were included, 14 completed the study protocol. Dried blood Phe concentrations as well as detailed dietary records were obtained throughout the study at preassigned study days.
Results: Eight patients could increase their Phe tolerance from 629 ± 476 mg to 2131 ± 1084 mg (P = 0.006) under BH4 while maintaining good metabolic control (Phe concentration in dried blood 283 ± 145 μM vs. 304 ± 136 μM, P = 1.0), therefore proving to be BH4-sensitive. They decreased their consumption of special low protein products and fruit while increasing their consumption of high protein foods such as processed meat, milk and dairy products. Intake of vitamin D (P = 0.016), iron (P = 0.002), calcium (P = 0.017), iodine (P = 0.005) and zinc (P = 0.046) significantly declined during BH4 treatment while no differences in energy and macronutrient supply occurred.
Conclusion: BH4-sensitive patients showed good metabolic control under markedly increased Phe consumption. However, the insufficient supply of some micronutrients needs consideration. Long-term multicenter settings with higher sample sizes are necessary to investigate the changes of nutrient intake under BH4 therapy to further evaluate potential risks of malnutrition. Supplementation may become necessary.
Competing interests: None declared
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Blau N, Bélanger-Quintana A, Demirkol M, Feillet F, Giovannini M, Mac Donald A, Trefz FK, van Spronson FJ (2009) Optimizing the use of sapropterin (BH4) in the management of phenylketonuria. Mol Genet Metab 96:158–163
Blau N, Hennermann JB, Langenbeck U, Lichter-Konecki U (2011) Diagnosis, classification, and genetics of phenylketonuria and tetrahydrobiopterin (BH4) deficiencies. Mol Genet Metab 104(Suppl):S2–S9
Bélanger-Quintana A, García MJ, Castro M, Desviat LR, Pérez B, Mejía B et al (2005) Spanish BH4-responsive phenylalanine hydroxylase-deficient patients: evolution of seven patients on long-term treatment with tetrahydrobiopterin. Mol Genet Metab 86(Suppl 1):S61–S66
Burgard P, Rey F, Rupp A, Abadie V, Rey J (1997) Neuropsychologic functions of early treated patients with phenylketonuria, on and off diet: results of a cross-national and cross-sectional study. Pediatr Res 41:368–374
Burlina A, Blau N (2009) Effect of BH(4) supplementation on phenylalanine tolerance. J Inherit Metab Dis 32:40–45
Burton BK, Grange DK, Milanowski A, Vockley G, Feillet F, Crombez EA et al (2007) The response of patients with phenylketonuria and elevated serum phenylalanine to treatment with oral sapropterin dihydrochloride (6R-tetrahydrobiopterin): a phase II, multicentre, open-label, screening study. J Inherit Metab Dis 30:700–707
Burton BK, Bausell H, Katz R, Laduca H, Sullivan C (2010) Sapropterin therapy increases stability of blood phenylalanine levels in patients with BH4-responsive phenylketonuria (PKU). Mol Genet Metab 101:110–114
Ceglarek U, Müller P, Stach B, Bührdel P, Thiery J, Kiess W (2002) Validation of the phenylalanine/tyrosine ratio determined by tandem mass spectrometry: sensitive newborn screening for phenylketonuria. Clin Chem Lab Med 40:693–697
De Bourdeaudhuij I, te Velde S, Brug J, Due P, Wind M, Sandvik C et al (2008) Personal, social and environmental predictors of daily fruit and vegetable intake in 11-year-old children in nine European countries. Eur J Clin Nutr 62:834–841
Elfhag K, Tholin S, Rasmussen F (2008) Consumption of fruit, vegetables, sweets and soft drinks are associated with psychological dimensions of eating behaviour in parents and their 12-year-old children. Public Health Nutrition 11:914–923
Fiori L, Fiege B, Riva E, Giovannini M (2005) Incidence of BH4-responsiveness in phenylalanine-hydroxylase-deficient Italian patients. Mol Genet Metab 86(Suppl 1):S67–S74
Germany (D), Austrian (A), Swiss (CH)DACH-Reference values for the intake of nutritive substances (Referenzwerte für die Nährstoffzufuhr, DGE 2000) Deutsche Gesellschaft für Ernährung e.V. (DGE), Österreichische Gesellschaft für Ernährung (ÖGE), die Schweizerische Gesellschaft für Ernährungsforschung SGE, Schweizerische Vereinigung für Ernährung: Referenzwerte für die Nährstoffzufuhr (Germany, [DACH, 2000] 1st ed Frankfurt am Main, Umschau/ Braus 2000
Hartmann B (2009) Bundeslebensmittelschluessel. Max-Rubner-Institut, Karlsruhe, Germany. http://www.bls.nvs2.de/index.php?id=37
Hennermann JB, Buhrer C, Blau N, Vetter B, Monch E (2005) Long-term treatment with tetrahydrobiopterin increases phenylalanine tolerance in children with severe phenotype of phenylketonuria. Mol Genet Metab 86(Suppl 1):S86–S90
Kaufman S, Berlow S, SUmmer GK, Milstien S, Schulman JD, Orloff S, Spielberg S, Pueschel S (1978) Hyperphenylalaninemia due to a deficiency of biopterin: a variant form of phenylketonuria. N Engl J Med 299:673–679
Kersting M, Alexy U (2005) iX—Empfehlungen für die Ernährung von Kindern und Jugendlichen (German). aid Infodienst, Bonn
Kremers SP, Brug J, de Vries H, Engels RC (2003) Parenting style and adolescent fruit consumption. Appetite 41:43–50
Lambruschini N, Pérez-Dueñas B, Vilaseca MA, Mas A, Artuch R, Gassió R et al (2005) Clinical and nutritional evaluation of phenylketonuric patients on tetrahydrobiopterin monotherapy. Mol Genet Metab 86(Suppl 1):S54–S60
Macdonald A (2000) Diet and compliance in phenylketonuria. Eur J Pediatr 159(Suppl 2):S136–S141
Macdonald A, Rylance G, Davis P, Asplin D, Hall SK, Booth IW (2003) Free use of fruits and vegetables in phenylketonuria. J Inherit Metab Dis 26:327–338
Macdonald A, Gokmen-Ozel H, van Rijn M, Burgard P (2010) The reality of dietary compliance in the management of phenylketonuria. J Inherit Metab Dis 33:665–670
Mensink GBM, Heseker H, Richter A et al (2007) Ernährungsstudie als KiGGS-Modul (EsKiMo). Forschungsbericht. RKI, UniversitätPaderborn, Berlin, Paderborn
Mütze U, Roth A, Weigel JF et al (2011) Transition of young adults with phenylketonuria from pediatric to adult care. J Inherit Metab Dis 34(3):701–709
Muntau AC, Roschinger W, Habich M et al (2002) Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria. N Engl J Med 347:2122–2132
Rohde C, Mütze U, Weigel J FK, Ceglarek U, Thiery J, Kiess W, Beblo S (2012) Unrestricted consumption of fruits and vegetables in phenylketonuria: no major impact on metabolic control. Eur J Clin Nutr. http://www.nature.com/ejcn/journal/vaop/ncurrent/full/ejcn2011205a.html
Schulz B, Bremer HJ (1995) Nutrient intake and food consumtion of adolescents and young adults with phenylketonuria. Acta Paediatr 84:743–748
Scriver CR, Kaufman S, Eisensmith RC, Woo SLC (1998) The hyperphenylalaninemias. In: Scriver RC, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease. McGraw-Hill, New York, pp 1015–1075
Singh RH, Quirk ME, Douglas TD, Brauchla MC (2010) BH(4) therapy impacts the nutrition status and intake in children with phenylketonuria: 2-year follow-up. J Inherit Metab Dis 33:689–696
Stemerdink BA, Kalverboer AF, van der Meere JJ et al (2000) Behaviour and school achievement in patients with early and continuously treated phenylketonuria. J Inher Metab Dis 23:548–562
Trefz FK, Burton BK, Longo N et al (2009) Efficacy of sapropterin dihydrochloride in increasing phenylalanine tolerance in children with phenylketonuria: a phase III, randomized, double-blind, placebo-controlled study. J Pediatr 154:700–707
Unuvar T, Buyukgebiz A (2010) Nutritional rickets and vitamin D deficiency in infants, children and adolescents. Pediatr Endocrinol Rev 7:283–291
Weglage J, Funders B, Wilken B et al (1992) Psychological and social findings in adolescents with phenylketonuria. Eur J Pediatr 151:522–525
Zabinski MF, Daly T, Norman GJ, Rupp JW, Calfas KJ, Sallis JF et al (2006) Psychosocial correlates of fruit, vegetable, and dietary fat intake among adolescent boys and girls. J Am Diet Assoc 106:814–821
Ziesch B, Weigel J, Thiele A, Mütze U, Rohde C, Ceglarek U, Thiery J, Kiess W, Beblo S (2012) Tetrahydrobiopterin (BH4) in PKU: effect on dietary treatment, metabolic control and quality of life. J Inher Metab Dis. doi:10.1007/s10545-012-9458-1
Zimmermann M, Jacobs P, Fingerhut R, Torresani T, Thöny B, Blau N, Baumgartner MR, Rohrbach M (2012) Positive effect of a simplified diet on blood phenylalanine control in different phenylketonuria variants, characterized by newborn BH4 loading test and PAH analysis. Mol Genet Metab 106:264–268
Acknowledgements
The authors would like to thank the patients and their families for their interest and participation. The help by the nurses at the hospital’s outpatient clinic is as much appreciated as that by the technicians in the department’s laboratory.
This work was partly supported by an investigator-initiated, unrestricted research grant from Merck-Serono GmbH.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Additional information
Communicated by: Anita MacDonald
Take Home Message
Take Home Message
Although BH4 therapy is an effective and helpful additional treatment in some patients with PKU, changes in eating habits and consequently insufficient supply of micronutrients has to be judged critically.
Rights and permissions
Copyright information
© 2012 SSIEM and Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Thiele, A.G. et al. (2012). Nutritional Changes and Micronutrient Supply in Patients with Phenylketonuria Under Therapy with Tetrahydrobiopterin (BH4). In: Zschocke, J., Gibson, K.M., Brown, G., Morava, E., Peters, V. (eds) JIMD Reports – Case and Research Reports, 2012/6. JIMD Reports, vol 9. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2012_176
Download citation
DOI: https://doi.org/10.1007/8904_2012_176
Received:
Revised:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-35517-2
Online ISBN: 978-3-642-35518-9
eBook Packages: MedicineMedicine (R0)